What to do for a 90-year-old patient with a dry cough on perindopril (angiotensin-converting enzyme inhibitor) and atelectasis on chest X-ray (CXR)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 8, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Dry Cough in a 90-Year-Old Patient on Perindopril with Atelectasis

For a 90-year-old patient with dry cough on perindopril and atelectasis on chest X-ray, discontinue the ACE inhibitor and switch to an angiotensin receptor blocker (ARB) as the most effective treatment approach. 1, 2

ACE Inhibitor-Induced Cough

  • Perindopril, like other ACE inhibitors, commonly causes a dry, persistent cough as a side effect in approximately 10-20% of patients 2
  • The diagnosis of ACE inhibitor-induced cough is confirmed by resolution of the cough after discontinuation of the medication, typically within 1-4 weeks (though it may take up to 3 months in some cases) 1
  • ACE inhibitor-induced cough is caused by the accumulation of bradykinin and substance P, which stimulates cough receptors 3
  • The only uniformly effective treatment for ACE inhibitor-induced cough is discontinuation of the ACE inhibitor 1

Management Strategy

Primary Intervention

  • Discontinue perindopril immediately regardless of the temporal relationship between the onset of cough and initiation of ACE inhibitor therapy 1
  • Switch to an angiotensin receptor blocker (ARB) as the preferred alternative since ARBs have a similar mechanism of action but do not affect bradykinin metabolism 2, 3
  • For a 90-year-old patient, start with a low-dose ARB such as losartan 25mg once daily or telmisartan 40mg once daily 2, 3
  • Monitor blood pressure, renal function, and potassium levels within 1-2 weeks after switching medications 3

Addressing Atelectasis

  • Atelectasis (collapsed and non-aerated region of lung parenchyma) may be exacerbated by the dry cough and requires separate management 4
  • Examine for air-bronchograms on chest X-ray to determine whether proximal or distal airway obstruction is involved 5
  • Consider chest physiotherapy and postural drainage to help clear secretions and re-expand collapsed lung tissue 4, 5
  • If mucous plugging is suspected, bronchodilator therapy may be helpful 4
  • For persistent atelectasis not responding to conservative measures, bronchoscopy may be necessary to remove mucous plugs 4, 5

Monitoring and Follow-up

  • After switching from perindopril to an ARB, expect resolution of cough within 1-4 weeks 1, 2
  • Pay particular attention to postural blood pressure changes in this elderly patient 3
  • Monitor for adequate blood pressure control, as the goal should be appropriate for a 90-year-old patient 1
  • If blood pressure control is inadequate on the initial ARB dose, the dose can be titrated upward (e.g., losartan to 50mg daily or telmisartan to 80mg daily) 2, 3
  • Follow up with repeat chest imaging to assess resolution of atelectasis after cough improvement 5

Important Considerations for Elderly Patients

  • Start with lower doses of ARBs in elderly patients and titrate slowly to avoid adverse effects 2
  • Be vigilant for potential side effects of ARBs including hypotension, hyperkalemia, and worsening renal function 3
  • Although rare, angioedema has been reported with ARBs in patients who previously experienced angioedema with ACE inhibitors 3
  • If ARBs are not tolerated, consider a calcium channel blocker as an alternative antihypertensive medication 2

By discontinuing perindopril and switching to an appropriate ARB, the patient's dry cough should resolve, which will also help improve the atelectasis by eliminating the persistent irritation to the airways.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of ACE Inhibitor-Induced Cough

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Switching from Perindopril to ARB for ACE Inhibitor-Induced Cough

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Atelectasis: mechanisms, diagnosis and management.

Paediatric respiratory reviews, 2000

Research

Treatment of atelectasis: where is the evidence?

Critical care (London, England), 2005

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.